Literature DB >> 16269614

Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions.

Rui Zhang1, Jeffrey D Lifson, Claire Chougnet.   

Abstract

Because interactions between activated CD4+ T cells and antigen-presenting cells (APCs) are crucial for optimal APC function, defective CD4+ T-cell activation may contribute to APC dysregulation in HIV infection. Here, we show that CD4+ T cells exposed during stimulation to noninfectious HIV having functional envelope glycoproteins failed to provide activation signals to autologous dendritic cells (DCs). Consequently, important DC functions, including production of immunoregulatory cytokines (interleukin-12 p40 and interleukin-10) and up-regulation of costimulatory molecules (CD86, CD40, CD83), as well as the capacity to stimulate naive allogeneic T cells, were all adversely affected. The blunted up-regulation of CD154 in CD4+ T cells that were activated in the presence of noninfectious viruses is likely to be the major underlying mechanism for these defects. Addition of recombinant trimeric CD154 could restore production of cytokines by DCs cocultured with HIV-exposed T cells. Moreover, the functional defects mediated by coculture with HIV-exposed T cells were similar to those following antibody blockade of CD40-CD154 interactions. HIV-mediated blunted CD154 expression may thus play an important role in the suppression of cell-mediated immunity seen in HIV infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16269614      PMCID: PMC1379663          DOI: 10.1182/blood-2005-07-2731

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  51 in total

1.  Dendritic cell longevity and T cell persistence is controlled by CD154-CD40 interactions.

Authors:  A J Miga; S R Masters; B G Durell; M Gonzalez; M K Jenkins; C Maliszewski; H Kikutani; W F Wade; R J Noelle
Journal:  Eur J Immunol       Date:  2001-03       Impact factor: 5.532

2.  Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production.

Authors:  C Chougnet; A Kovacs; R Baker; B U Mueller; N L Luban; D J Liewehr; S M Steinberg; E K Thomas; G M Shearer
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

Review 3.  CD40-CD40 ligand.

Authors:  C van Kooten; J Banchereau
Journal:  J Leukoc Biol       Date:  2000-01       Impact factor: 4.962

4.  In vivo CD40-CD154 (CD40 ligand) interaction induces integrated HIV expression by APC in an HIV-1-transgenic mouse model.

Authors:  C Chougnet; C Freitag; M Schito; E K Thomas; A Sher; G M Shearer
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

5.  Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection.

Authors:  G Vanham; L Penne; J Devalck; L Kestens; R Colebunders; E Bosmans; K Thielemans; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

6.  Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia.

Authors:  M V Jones; J E Bell; A Nath
Journal:  AIDS       Date:  2000-12-01       Impact factor: 4.177

7.  An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages.

Authors:  I M Wang; C Contursi; A Masumi; X Ma; G Trinchieri; K Ozato
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

8.  Restoration of anti-human immunodeficiency virus type 1 (HIV-1) responses in CD8+ T cells from late-stage patients on prolonged antiretroviral therapy by stimulation in vitro with HIV-1 protein-loaded dendritic cells.

Authors:  Z Fan; X L Huang; L Borowski; J W Mellors; C R Rinaldo
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

9.  Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: investigation of the mechanism of inhibition.

Authors:  C Spenlehauer; A Kirn; A M Aubertin; C Moog
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

10.  Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells.

Authors:  H Jonuleit; E Schmitt; G Schuler; J Knop; A H Enk
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

View more
  15 in total

1.  Highly active antiretroviral therapy in patients infected with human immunodeficiency virus increases CD40 ligand expression and IL-12 production in cells ex vivo.

Authors:  Alice M Nyakeriga; Jun Ying; Norah J Shire; Carl J Fichtenbaum; Claire A Chougnet
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

Review 2.  Natural regulatory T cells and persistent viral infection.

Authors:  Shuo Li; Eric J Gowans; Claire Chougnet; Magdalena Plebanski; Ulf Dittmer
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

3.  Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV.

Authors:  Rongxin Zhang; Sheng Zhang; Min Li; Changyi Chen; Qizhi Yao
Journal:  Vaccine       Date:  2010-05-14       Impact factor: 3.641

4.  EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine.

Authors:  Sachin Gupta; James M Termini; Liguo Niu; Saravana K Kanagavelu; Helena Schmidtmayerova; Victoria Snarsky; Richard S Kornbluth; Geoffrey W Stone
Journal:  J Leukoc Biol       Date:  2011-05-17       Impact factor: 4.962

5.  A GxxxG-like motif within HIV-1 fusion peptide is critical to its immunosuppressant activity, structure, and interaction with the transmembrane domain of the T-cell receptor.

Authors:  Omri Faingold; Tomer Cohen; Yechiel Shai
Journal:  J Biol Chem       Date:  2012-08-07       Impact factor: 5.157

6.  Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions.

Authors:  Filippos Porichis; Meghan G Hart; Jennifer Zupkosky; Lucie Barblu; Douglas S Kwon; Ashley McMullen; Thomas Brennan; Rafi Ahmed; Gordon J Freeman; Daniel G Kavanagh; Daniel E Kaufmann
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

7.  An immunomodulating motif of the HIV-1 fusion protein is chirality-independent: implications for its mode of action.

Authors:  Omri Faingold; Avraham Ashkenazi; Nathali Kaushansky; Avraham Ben-Nun; Yechiel Shai
Journal:  J Biol Chem       Date:  2013-09-27       Impact factor: 5.157

8.  HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.

Authors:  Jakob Nilsson; Adriano Boasso; Paula Andrea Velilla; Rui Zhang; Monica Vaccari; Genoveffa Franchini; Gene M Shearer; Jan Andersson; Claire Chougnet
Journal:  Blood       Date:  2006-08-10       Impact factor: 22.113

9.  FOXP3 expression is upregulated in CD4T cells in progressive HIV-1 infection and is a marker of disease severity.

Authors:  Melinda S Suchard; Elizabeth Mayne; Victoria A Green; Sharon Shalekoff; Samantha L Donninger; Wendy S Stevens; Clive M Gray; Caroline T Tiemessen
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

10.  Characterization of human immunodeficiency virus type 1 replication in immature and mature dendritic cells reveals dissociable cis- and trans-infection.

Authors:  Chunsheng Dong; Alicia M Janas; Jian-Hua Wang; Wendy J Olson; Li Wu
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.